1 1347 180 HYPOXIA IN CNS PATHOLOGIES: EMERGING ROLE OF MIRNA-BASED NEUROTHERAPEUTICS AND YOGA BASED ALTERNATIVE THERAPIES. CELLULAR RESPIRATION IS A VITAL PROCESS FOR THE EXISTENCE OF LIFE. ANY CONDITION THAT RESULTS IN DEPRIVATION OF OXYGEN (ALSO TERMED AS HYPOXIA) MAY EVENTUALLY LEAD TO DELETERIOUS EFFECTS ON THE FUNCTIONING OF TISSUES. BRAIN BEING THE HIGHEST CONSUMER OF OXYGEN IS PRONE TO INCREASED RISK OF HYPOXIA-INDUCED NEUROLOGICAL INSULTS. THIS IN TURN HAS BEEN ASSOCIATED WITH MANY DISEASES OF CENTRAL NERVOUS SYSTEM (CNS) SUCH AS STROKE, ALZHEIMER'S, ENCEPHALOPATHY ETC. ALTHOUGH SEVERAL STUDIES HAVE INVESTIGATED THE PATHOPHYSIOLOGICAL MECHANISMS UNDERLYING ISCHEMIC/HYPOXIC CNS DISEASES, THE KNOWLEDGE ABOUT PROTECTIVE THERAPEUTIC STRATEGIES TO AMELIORATE THE AFFECTED NEURONAL CELLS IS MEAGER. THIS HAS AUGMENTED THE NEED TO IMPROVE OUR UNDERSTANDING OF THE HYPOXIC AND ISCHEMIC EVENTS OCCURRING IN THE BRAIN AND IDENTIFY NOVEL AND ALTERNATE TREATMENT MODALITIES FOR SUCH INSULTS. MICRORNA (MIRNAS), SMALL NON-CODING RNA MOLECULES, HAVE RECENTLY EMERGED AS POTENTIAL NEUROPROTECTIVE AGENTS AS WELL AS TARGETS, UNDER HYPOXIC CONDITIONS. THESE 18-22 NUCLEOTIDE LONG RNA MOLECULES ARE PROFUSELY PRESENT IN BRAIN AND OTHER ORGANS AND FUNCTION AS GENE REGULATORS BY CLEAVING AND SILENCING THE GENE EXPRESSION. IN BRAIN, THESE ARE KNOWN TO BE INVOLVED IN NEURONAL DIFFERENTIATION AND PLASTICITY. THEREFORE, TARGETING MIRNA EXPRESSION REPRESENTS A NOVEL THERAPEUTIC APPROACH TO INTERCEDE AGAINST HYPOXIC AND ISCHEMIC BRAIN INJURY. IN THE FIRST PART OF THIS REVIEW, WE WILL DISCUSS THE NEUROPHYSIOLOGICAL CHANGES CAUSED AS A RESULT OF HYPOXIA, FOLLOWED BY THE CONTRIBUTION OF HYPOXIA IN THE NEURODEGENERATIVE DISEASES. SECONDLY, WE WILL PROVIDE RECENT UPDATES AND INSIGHTS INTO THE ROLES OF MIRNA IN THE REGULATION OF GENES IN OXYGEN AND GLUCOSE DEPRIVED BRAIN IN ASSOCIATION WITH CIRCADIAN RHYTHMS AND HOW THESE CAN BE TARGETED AS NEUROPROTECTIVE AGENTS FOR CNS INJURIES. FINALLY, WE WILL EMPHASIZE ON ALTERNATE BREATHING OR YOGIC INTERVENTIONS TO OVERCOME THE HYPOXIA ASSOCIATED ANOMALIES THAT COULD ULTIMATELY LEAD TO IMPROVEMENT IN CEREBRAL PERFUSION. 2017 2 1257 19 FETAL AND MATERNAL RESPONSES TO YOGA IN THE THIRD TRIMESTER. OBJECTIVE: THE PRIMARY PURPOSE OF THIS STUDY WAS TO EXAMINE MATERNAL AND FETAL RESPONSES TO A TYPICAL, MODERATE-INTENSITY YOGA SESSION IN HEALTHY PREGNANT WOMEN DURING THE THIRD TRIMESTER USING CONTINUOUS MONITORING.METHODS: THIS PROSPECTIVE OBSERVATIONAL STUDY IN LOW-RISK, PREGNANT WOMEN USED THE MONICA AN24 ABDOMINAL ECG WIRELESS MATERNAL-FETAL MONITOR TO MEASURE FETAL HEART RATE, MATERNAL HEART RATE, AND UTERINE ACTIVITY DURING A PRENATAL YOGA SESSION. SESSIONS INCLUDED 4 TIME PERIODS: (1) 20-MINUTE REST, (2) 50 MINUTES STANDARD PRENATAL YOGA, (3) 10-MINUTE MEDITATION, (4) 20-MINUTE RECOVERY. DATA WERE CONTINUOUSLY RECORDED THROUGHOUT THE ENTIRE SESSION, STORED AT 0.25-SECOND INTERVALS, AND THEN AVERAGED OVER 5-MINUTE INTERVALS. TO EVALUATE CHANGES OVER TIME, OVERALL MEANS FOR THE FOUR TIME PERIODS (REST, YOGA, MEDITATION, RECOVERY) WERE COMPARED USING ONE-WAY ANOVA WITH REPEATED MEASURES. POST-HOC PAIRWISE COMPARISONS (TUKEY'S) WERE USED TO PROBE SIGNIFICANT DIFFERENCES BETWEEN THE FOUR TIME POINTS. STATISTICAL SIGNIFICANCE WAS REACHED AT P < .05.RESULTS: TWENTY PARTICIPANTS WERE ENROLLED; 19 COMPLETED THE YOGA SESSION. MEAN GESTATIONAL AGE WAS 35 WEEKS AND 6 DAYS (RANGE OF 32-0/7 TO 38-6/7) WITH AN AVERAGE PARTICIPANT AGE OF 32 +/- 2.7 YEARS. MATERNAL HEART RATES SIGNIFICANTLY INCREASED DURING THE YOGA PERIOD (102 +/- 11 BPM) COMPARED TO REST (90 +/- 10), MEDITATION (85 +/- 12), AND RECOVERY (88 +/- 10) (P < .01). THE MAXIMUM MATERNAL HEART RATE REACHED DURING THE YOGA SESSION WAS 125 +/- 13 BPM. WHILE FETAL HEART RATES FLUCTUATED SLIGHTLY OVER THE COURSE OF THE YOGA SESSION, THERE WERE NO SIGNIFICANT FETAL HEART RATE DECELERATIONS TO SUGGEST DELETERIOUS FETAL EFFECTS. THERE WERE NO STATISTICALLY SIGNIFICANT DIFFERENCES AMONG RESTING (138 +/- 14 BPM), YOGA (137 +/- 11 BPM), MEDITATION (139 +/- 7 BPM), OR RECOVERY (135 +/- 22 BPM) FETAL HEART RATES (P = .814). UTERINE ACTIVITY WAS SIGNIFICANTLY GREATER DURING THE YOGA PERIOD COMPARED WITH THE OTHER TIME POINTS (P < .001).CONCLUSION: YOGA CAN BE RECOMMENDED FOR LOW-RISK WOMEN DURING PREGNANCY AS NO ADVERSE FETAL OR MATERNAL HEART RATE CHANGES WERE OBSERVED DURING A TYPICAL PRENATAL YOGA SESSION. 2020 3 2743 33 YOGA PRACTICE IMPROVES EXECUTIVE FUNCTION BY ATTENUATING STRESS LEVELS. BACKGROUND: PROLONGED ACTIVATION OF THE HYPOTHALAMUS-PITUITARY-ADRENAL SYSTEM IS THOUGHT TO HAVE DELETERIOUS EFFECTS ON BRAIN FUNCTION. NEUROENDOCRINE STUDIES SUGGEST THAT BRAIN EXPOSURE TO HIGHER CORTISOL CONCENTRATIONS CONTRIBUTE TO COGNITIVE DEFICITS AS WE AGE. MIND-BODY TECHNIQUES SUCH AS YOGA HAVE SHOWN TO IMPROVE STRESS LEVELS BY RESTORING THE BODY'S SYMPATHETIC-PARASYMPATHETIC BALANCE. THE OBJECTIVE OF THIS STUDY WAS TO DETERMINE WHETHER YOGA PRACTICE MODERATED THE STRESS RESPONSE RESULTING IN IMPROVED EXECUTIVE FUNCTION. METHODS: SEDENTARY COMMUNITY DWELLING OLDER ADULTS (N=118, MEAN AGE=62.02) WERE RANDOMIZED TO AN 8-WEEK YOGA INTERVENTION OR A STRETCHING CONTROL GROUP. AT BASELINE AND FOLLOWING 8 WEEKS, ALL PARTICIPANTS COMPLETED MEASURES OF EXECUTIVE FUNCTION, SELF-REPORTED STRESS AND ANXIETY AND PROVIDED SALIVA SAMPLES BEFORE AND AFTER COGNITIVE TESTING TO ASSESS CORTISOL. RESULTS: YOGA PARTICIPANTS SHOWED IMPROVED ACCURACY ON EXECUTIVE FUNCTION MEASURES AND AN ATTENUATED CORTISOL RESPONSE COMPARED TO THEIR STRETCHING COUNTERPARTS WHO SHOWED INCREASED CORTISOL LEVELS AND POOR COGNITIVE PERFORMANCE AT FOLLOW UP. THE CHANGE IN CORTISOL LEVELS AS WELL AS SELF-REPORTED STRESS AND ANXIETY LEVELS PREDICTED PERFORMANCE ON THE RUNNING SPAN TASK, N-BACK WORKING MEMORY AND TASK SWITCHING PARADIGM (BETA'S=0.27-0.38, P'S